In murine models, overexpression of MAD1L1 decreases p53 levels and promotes inflammation-driven colon tumorigenesis [76], while altered expression of this gene has been associated with poor prognosis and recurrence in hepatocellular carcinoma [77]. This evidence concerns the gene TP53 and hepatocellular carcinoma.